SCHEMBL24176308

SCHEMBL24176308

COC(c1ccc2ccccc2c1)C(C)(C)O

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ UGT2B7 P16662 1/20 0.50
▸ AOC3 Q16853 2/20 0.45
▸ SLC6A2 P23975 4/20 0.44
▸ SLC6A4 P31645 4/20 0.44
▸ SLC6A3 Q01959 4/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ ATM Q13315 1/20 0.44
▸ CYP2D6 P10635 3/20 0.42
▸ CYP3A4 P08684 2/20 0.42
▸ KCNH2 Q12809 2/20 0.42
▸ CYP1A2 P05177 2/20 0.41
▸ CYP2A6 P11509 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ HIF1A Q16665 1/20 0.41
▸ MLKL Q8NB16 1/20 0.40
▸ GABBR2 O75899 1/20 0.39
▸ GABBR1 Q9UBS5 1/20 0.39
▸ MMP9 P14780 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL808938 0.75 UGT2B7 (0.53) UGT2B7AOC3SLC6A2SLC6A4SLC6A3
SCHEMBL808636 0.75 UGT2B7 (0.53) UGT2B7AOC3SLC6A2SLC6A4SLC6A3
SCHEMBL808826 0.75 UGT2B7 (0.53) UGT2B7AOC3SLC6A2SLC6A4SLC6A3
SCHEMBL20172068 0.74 AKR1C3 (0.39) KMT2AATMCYP1A2TSHR
SCHEMBL20976148 0.74 UGT2B7 (0.62) UGT2B7AOC3SLC6A2SLC6A4SLC6A3
SCHEMBL4411103 0.74 UGT2B7 (0.55) UGT2B7AOC3SLC6A2SLC6A4SLC6A3
SCHEMBL1753651 0.72 UGT2B7 (0.59) UGT2B7AOC3SLC6A2SLC6A4SLC6A3
SCHEMBL15345447 0.71 AOC3 (0.54) UGT2B7AOC3SLC6A2SLC6A4SLC6A3
SCHEMBL7699358 0.71 UGT2B7 (0.52) UGT2B7AOC3SLC6A2SLC6A4SLC6A3
SCHEMBL16174482 0.71 AOC3 (0.54) UGT2B7AOC3SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11584773-B2 Phosphorous protecting groups and methods of preparation and use thereof AGILENT TECHNOLOGIES, INC. (US) 2023-02-21 — — US disclosed
US-20220002334-A1 PHOSPHOROUS PROTECTING GROUPS AND METHODS OF PREPARATION AND USE THEREOF UNIVERSITY OF COLORADO BOULDER 2022-01-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220002334-A1 PHOSPHOROUS PROTECTING GROUPS AND METHODS OF PREPARATION AND USE THEREOF POLN, POLRMT, NUDT21 UGT2B7 3516/4885AOC3 1604/4885SLC6A2 1484/4885
US-11584773-B2 Phosphorous protecting groups and methods of preparation and use thereof POLN, POLRMT, NUDT21 UGT2B7 3516/4885AOC3 1604/4885SLC6A2 1484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback